Table 2.

Kidney biopsy details

	Total	Africa	Asia	Others
Proportion getting kidney biopsy when indicated	(N = 250)	(N = 131)	(N = 113)	(N = 6)
<10%	72 (28.8%)	66 (50.4%)	05 (4.5%)	1 (16.7%)
10–25%	48 (19.2%)	30 (22.9%)	17 (15.0%)	1 (16.7%)
26–50%	32 (12.8%)	14 (10.7%)	17 (15.0%)	2 (33.3%)
>50%	98 (39.2%)	21 (16.0%)	74 (65.5%)	2 (33.3%)
No of kidney biopsies in a month	(N = 259)	(N = 101)	(N = 153)	(N = 5)
Not done	0 (0%)	0 (0%)	0 (0%)	0 (0%)
0–5	117 (45.2%)	67 (66.3%)	49 (32.0%)	1(20%)
5–10	62 (23.9%)	21 (20.8%)	39 (25.5%)	2 (40%)
More than 10	80 (30.9%)	13 (12.9%)	65 (42.5%)	2 (40%)
Mean turn-around time (ds)	(N = 257)	(N = 99)	(N = 153)	(N = 5)
< 3	48 (18.7%)	05 (5.0%)	42 (27.4%)	1(20%)
3–7	96 (37.3%)	17 (17.2%)	78 (51.0%)	1(20%)
8–14	72 (28.0%)	42 (42.4%)	28 (18.3%)	2 (40%)
>14	41 (16.0%)	35 (35.4%)	05 (3.3%)	1 (20%)
Location of the nephro-pathology service	(N = 253)	(N = 97)	(N = 151)	(N = 5)
In my hospital	106 (41.9%)	44 (45.4%)	62 (41.0%)	0 (0%)
In my city	54 (21.3%)	11 (11.3%)	38 (25.2%)	5 (100%)
Another city	54 (21.3%)	14 (14.4%)	40 (26.5%)	0 (0%)
Overseas	39 (15.5%)	28 (28.9%)	11 (7.3%)	0 (0%)
Biopsies processed	(N = 246)	(N = 89)	(N = 152)	(N = 5)
LM only	41 (16.7%)	38 (42.7%)	03 (2.0%)	0 (0%)
LM and IF	98 (39.8%)	25 (28.1%)	69 (45.4%)	4 (80%)
LM, IF and EM	107 (43.5%)	26 (29.2%)	80 (52.6%)	1 (20%)
Proportion of biopsies evaluated by IF/IHC	(N = 252)	(N = 94)	(N = 153)	(N = 5)
<10%	59 (23.5%)	52 (55.4%)	06 (3.9%)	1 (20%)
11–50%	20 (7.9%)	10 (10.6%)	10 (6.5%)	0 (0%)
50–75%	16 (6.3 %)	07 (7.4%)	09 (5.9%)	0 (0%)
>75%	157 (62.3%)	25 (26.6%)	128 (83.7%)	4 (80%)
Proportion of biopsies evaluated by EM	(N = 243)	(N = 90)	(N = 148)	(N = 5)
<10%	167 (68.7%)	73 (81.2%)	90 (60.8%)	4 (80%)
11–50%	29 (11.9%)	04 (4.4%)	25 (16.9%)	0 (0%)
50–75%	16 (6.6%)	03 (3.3%)	13 (8.8%)	0 (0%)
>75%	31 (12.8%)	10 (11.1%)	20 (13.5%)	1 (20%)

EM, electron microscopy; IF, immunofluorescence; IHC, immunohistochemistry; LM, light microscopy.